1 |
Kalivas, P. W. and Duffy, T. (1998) Repeated cocaine administration
alters extracellular glutamate levels in the ventral tegmental area.
J. Neurochem. 70, 1497-1502.
|
2 |
Kalivas, P. W. and O’Brien, C. (2008) Drug addiction as a pathology of
staged neuroplasticity. Neuropsychopharmacol. 33, 166-180.
DOI
|
3 |
Kankaanpaa, A., Meririnne, E. and Seppala, T. (2002) 5-HT3 receptor
antagonist MDL 72222 attenuates cocaine- and mazindol-, but not
methylphenidate-induced neurochemical and behavioral effects in
the rat. Psychopharmacol. (Ber) 159, 341-350.
DOI
|
4 |
Grimm, J. W., Lu, L., Hayashi, T., Hope, B. T., Su, T. P. and Shaham,
Y. (2003) Time-dependent increases in brain-derived neurotrophic
factor protein levels within the mesolimbic dopamine system after
withdrawal from cocaine: implications for incubation of cocaine
craving. J. Neurosci. 23, 742-747.
|
5 |
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C. and Sokoloff,
P. (2001) BDNF controls dopamine D3 receptor expression and
triggers behavioural sensitization. Nature. 411, 86-89.
DOI
|
6 |
Heal, D. J., Cheetham, S. C. and Smith, S. L. (2009) The neuropharmacology
of ADHD drugs in vivo: Insights on effi cacy and safety.
Neuropharmacol. 57, 7-8.
|
7 |
Hechtman, L. and Greenfi eld, B. (2003) Long-term use of stimulants in
children with attention defi cit hyperactivity disorder: safety, efficacy,
and long-term outcome. Paediatr. Drugs 5, 787-794.
DOI
ScienceOn
|
8 |
Heil, S. H., Holmes, H. W., Bickel, W. K., Higgins, S. T., Badger, G. J.,
Laws, H. F. and Faries, D. E. (2002) Comparison of the subjective,
physiological, and psychomotor effects of atomoxetine and methylphenidate
in light drug users. Drug Alcohol Depend. 67, 149-156.
DOI
|
9 |
Herges, S. and Taylor, D. A. (1998) Involvement of serotonin in the
modulation of cocaine-induced locomotor activity in the rat. Pharmacol.
Biochem. Behav. 59, 595-611.
DOI
|
10 |
Himelstein, J., Newcorn, J. H. and Halperin, J. M. (2000) The neurobiology
of attention-deficit hyperactivity disorder. Front. Biosci. 5,
D461-D478.
DOI
|
11 |
Hiroi, N., Brown, J. R., Haile, C. N., Ye, H., Greenberg, M. E. and
Nestler, E. J. (1997) FosB mutant mice: Loss of chronic cocaine
induction of Fos-related proteins and heightened sensitivity to cocaine's
psychomotor and rewarding effects. Proc. Natl. Acad. Sci.
USA. 94, 10397-10402.
DOI
|
12 |
Hooks, M. S., Jones, G. H., Neill, D. B. and Justice, J. B. (1991) Individual
differences in amphetamine sensitization: dose-dependent
effects. Pharmacol. Biochem. Behav. 41, 203-210.
|
13 |
Faraone, S. V. and Biederman, J. (2005) What is the prevalence of
adult ADHD? Results of a population screen of 966 adults. J. Atten.
Dissord. 9, 384-391.
DOI
|
14 |
Faraone, S. V., Wigal, S. B. and Hodgkins, P. (2007) Forecasting
three-month outcomes in a laboratory school comparison of mixed
amphetamine salts extended release (Adderall XR) and atomoxetine
(Strattera) in school-aged children with ADHD. J. Atten. Disord.
11, 74-82.
DOI
|
15 |
Fumagalli, F., Cattaneo, A., Caffi no, L., Ibba, M., Racagni, G., Carboni,
E., Gennarelli, M. and Riva, M. A. (2010) Sub-chronic exposure to
atomoxetine up-regulates BDNF expression and signalling in the
brain of adolescent spontaneously hypertensive rats: Comparison
with methylphenidate. Pharmacol. Res. 62, 523-529.
DOI
|
16 |
Gao, W. Y., Lee, T. H., King, G. R. and Ellinwood, E. H. (1998) Alterations
in baseline activity and quinpirole sensitivity in putative dopamine
neurons in the substantia nigra and ventral tegmental area
after withdrawal from cocaine pretreatment. Neuropsychophamacol.
18, 222-232.
DOI
|
17 |
Gardier, A. M., Moratalla, R., Cuellar, B., Sacerdote, M., Guibert, B.,
Lebrec, H. and Graybiel, A. M. (2000) Interaction between the serotoninergic
and dopaminergic systems in d-fenfl uramine-induced
activation of cfos and jun B genes in rat striatal neurons. J. Neurochem.
74, 1363-1373.
|
18 |
Yang, P., Behrang, A., Swann, A. and Nachum, D. (2003) Strain differences
in the behavioral responses of male rats to chronically
administered methylphenidate. Brain Res. 971, 139-152.
DOI
|
19 |
Yano, M. and Steiner, H. (2005a) Methylphenidate (Ritalin) induces
Homer 1a and zif 268 expression in specific corticostriatal circuits.
Neurosci. 132, 855-865.
DOI
|
20 |
Yano, M. and Steiner, H. (2005b) Topography of methylphenidate
(Ritalin)-induced gene regulation in the striatum: differential effects
on c-fos, substance P and opioid peptides. Neuropsychopharmacol.
30, 901-915.
DOI
|
21 |
Gasior, M., Bergman, J., Kallman, M. J. and Paronis, C. A. (2005) Evaluation
of the reinforcing effects of monoamine reuptake inhibitors
under a concurrent schedule of food and i.v. drug delivery in rhesus
monkeys. Neuropsychopharmacol. 30, 758-764.
|
22 |
Goldman-Rakic, P. S. (1996) Cellular basis of working memory. Neuron
14, 477-485.
|
23 |
Grimes, C. A. and Jope, R. S. (2001) The multifaceted roles of glycogen
synthase kinase 3beta in cellular signaling. Prog. Neurobiol.
65, 391-426.
DOI
|
24 |
Chase, T. D., Carrey, N., Brown, R. E. and Wilkinson, M. (2005a) Methylphenidate
regulates c-fos and fosB expression in multiple regions
of the immature rat brain. Brain Res. Dev. Brain Res. 156, 1-12.
DOI
ScienceOn
|
25 |
Chase, T. D., Carrey, N., Brown, R. E. and Wilkinson, M. (2005b)
Methylphenidate differentially regulates c-fos and fosB expression
in the developing rat striatum. Dev. Brain Res. 157, 181-191.
DOI
|
26 |
Chase, T., Carrey, N., Soo, E. and Wilkinson, M. (2007) Methylphenidate
regulates activity regulated cytoskeletal associated but not
brain-derived neurotrophic factor gene expression in the developing
rat striatum. Neurosci. 144, 969-984.
DOI
|
27 |
Commons, K. G. (2010) Neuronal pathways linking substance P to
drug addiction and stress. Brain Res. 1314, 175-182.
DOI
|
28 |
Zhang, X. F., Hu, X. T., White, F. J. and Wolf, M. E. (1997) Increased responsiveness of ventral tegmental area dopamine neurons to glutamate
after repeated administration of cocaine or amphetamine is
transient and selectively involves AMPA receptors. J. Pharmacol.
Exp. Ther. 281, 699-706.
|
29 |
Yano, M., Beverley, J. A. and Steiner, H. (2006) Inhibition of methylphenidate-induced gene expression in the striatum by local blockade
of D1 receptors: Interhemispheric effects. Neurosci. 140, 699-709.
DOI
ScienceOn
|
30 |
Yano, M. and Steiner, H. (2007) Methylphenidate and cocaine:the
same effects on gene regulation. Trends in Pharmacol Sci. 28,
588-596.
DOI
ScienceOn
|
31 |
White, F. J., Hu, X. T., Zhang, X. F. and Wolf, M. E. (1995) Repeated
administration of cocaine or amphetamine alters neuronal responses
to glutamate in the mesoaccumbens dopamine system. J. Pharmacol.
Exp. Ther. 273, 445-454.
|
32 |
White, F. J. and Wolf, M. E. (1991) Psychomotor stimulants. In The
Biological Basis of Drug Tolerance and Dependence (J. A. Pratt,
Ed.), pp. 153-197. Academic Press, London,
DOI
|
33 |
Everitt, B. J. and Robbins,T. W. (2005) Neural systems of reinforcement
for drug addiction: From actions to habits to compulsion. Nat.
Neurosci. 8, 1481-1489.
DOI
|
34 |
Cotterly, L., Beverley, J. A., Yano, M. and Steiner, H. (2007) Dysregulation
of gene induction in corticostriatal circuits after repeated methylphenidate
treatment in adolescent rats: Differential effects on zif
268 and homer 1a. Eur. J. Neurosci. 25, 3617-3628.
DOI
|
35 |
Daunais, J. B. and McGinty, J. F. (1994) Acute and chronic cocaine
administration differentially alters striatal opioid and nuclear transcription
factor mRNAs. Synapse 18, 35-45.
DOI
|
36 |
de la Pena, I. C., Ahn, H. S., Choi, J. Y., Shin, C. Y., Ryu, J. H. and
Cheong, J. H. (2011) Methylphenidate self-adminstration and conditioned
place preference in an animal model of attention deficit
hyperactivity disorder-the spontaneously hypertensive rat. Behav.
Pharmacol. 22, 31-39.
DOI
ScienceOn
|
37 |
Evans, C., Blackburn, D. and Butt, P. (2004) Use and abuse of methylphenidate
in attention-deficit hyperactivity disorder. CPJ/RPC 137,
30-33.
|
38 |
Biederman, J., Wigal, S. B., Spencer, T. J., McGough, J. J. and Mays,
D. A. (2006) A post hoc subgroup analysis of an 18-day randomized
controlled trial comparing the tolerability and effi cacy of mixed
amphetamine salts extended release and atomoxetine in school-age
girls with attention-deficit/hyperactivity disorder. Clin. Ther. 28,
280-293.
DOI
|
39 |
Bonci, A., Bernardi, G., Grillner, P. and Mercuri, N. B. (2003) The dopamine-containing neuron: maestro or simple musician in the orchestra
of addiction. Trends Pharmacol. Sci. 24, 172-177.
DOI
|
40 |
Bramham, C. R. and Messaoudi, E. (2005). BDNF function in adult
synaptic plasticity: the synaptic consolidation hypothesis. Prog.
Neurobiol. 76, 99-125.
DOI
|
41 |
Willuhn, I., Sun, W. and Steiner, H. (2003) Topography of cocaine-induced
gene regulation in the rat striatum: relationship to cortical
inputs and role of behavioral context. Eur. J. Neurosci. 17, 1053-1066.
DOI
|
42 |
Wigal, S. B., McGough, J. J., McCracken, J. T., Biederman, J., Spencer,
T. J., Posner, K. L., Wigal, T. L., Kollins, S. H., Clark, T. M.,
Mays, D. A., Zhang, Y. and Tulloch, S. J. (2005) A laboratory school
comparison of mixed amphetamine salts extended release (Adderall
XR) and atomoxetine (Strattera) in school-aged children with
attention deficit/hyperactivity disorder. J. Atten. Disord. 9, 275-289.
DOI
|
43 |
Wilens, T. E., Faraone, S. V., Biederman, J. and Gunawardene, S.
(2003) Does stimulant therapy of attention-deficit/hyperactivity disorder
beget later substance abuse? A meta-analytic review of the
literature. Pediatrics 111, 179-185.
DOI
ScienceOn
|
44 |
Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle,
R., Utzinger, L. and Fusillo, S. (2008) Misuse and diversion of
stimulants prescribed for ADHD: a systematic review of the literature.
J Am. Acad. Child. Adolesc. Psychiatry 47, 21-31.
DOI
|
45 |
Xiao, B., Tu, J. C. and Worley. P. (2000) Homer: a link between neural
activity and glutamate receptor function. Curr. Opin. Neurobiol. 10,
370-374.
DOI
|
46 |
Xue, C. J., Ng, J. P., Li, Y. and Wolf, M. E. (1996) Acute and repeated
systemic amphetamine administration: Effects on extracellular glutamate,
aspartate, and serine levels in rat ventral tegmental area
and nucleus accumbens. J. Neurochem. 67, 352-363.
DOI
|
47 |
Volkow, N. D., Fowler, J. S., Wang, G. J., Ding, Y. S. and Gatley, S. J.,
(2002a) Role of dopamine in the therapeutic and reinforcing effects
of methylphenidate in humans: results from imaging studies. Eur.
J. Neuropsychopharmacol. 12, 557-566.
DOI
|
48 |
Carlezon, W. A. Jr. and Nestler, E. J. (2002) Elevated levels of GluR1
in the midbrain: a trigger for sensitization to drugs of abuse? Trends
Neurosci. 25, 610-615.
DOI
|
49 |
Brandon, C. L. and Steiner, H. (2003) Repeated methylphenidate
treatment in adolescent rats alters gene regulation in the striatum.
Eur. J. Neurosci. 18, 1584-1592.
DOI
|
50 |
Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K.,
Threlkeld, P. G., Heiligenstein, J. H., Morin, S. M., Gehlert, D. R.
and Perry, K. W. (2002) Atomoxetine increases extracellular levels
of norepinephrine and dopamine in prefrontal cortex of rat: a
potential mechanism for efficacy in attention deficit/hyperactivity
disorder. Neuropsychopharmacol. 27, 699-711.
DOI
|
51 |
Chao, J. and Nestler, E. J. (2004) Molecular neurobiology of drug addiction.
Annu. Rev. Med. 55, 113-132.
DOI
|
52 |
Chase, T. D., Brown, R. E., Carrey, N., Wilkinson, M., Chase, T. D.,
Brown, R. E., Carrey, N. and Wilkinson, M. (2003) Daily methylphenidate
administration attenuates c-fos expression in the striatum of
prepubertal rats. Neuroreport 14, 769-772.
DOI
|
53 |
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C. and
Carlezon, W. A. Jr. (2002) Altered responsiveness to cocaine in
rats exposed to methylphenidate during development. Nat. Neurosci.
5, 13-14.
DOI
|
54 |
Arnsten A. F. (2006) Stimulants: therapeutic actions in ADHD. Neuropsychopharmacol.
31, 2376-2383.
DOI
|
55 |
Askenasy, E. P., Taber, K. H., Yang, P. B. and Dafny, N. (2007) Methylphenidate
(Ritalin): behavioral studies in the rat. Intern. J. Neurosci. 117, 757-794.
DOI
ScienceOn
|
56 |
Wee, S. and Woolverton, W. L. (2004) Evaluation of the reinforcing
effects of atomoxetine in monkeys: comparison to methylphenidate
and desipramine. Drug and Alc. Dep. 75, 271-276.
DOI
|
57 |
Volkow, N. D., Wang, G. J., Fowler, J. S., Logan, J., Gatley, S. J.,
Wong, C., Hitzemann, R. and Pappas, N. R. (1999) Reinforcing effects
of psychostimulants in humans are associated with increases
in brain dopamine and occupancy of D(2) receptors. J. Pharmacol.
Exp. Ther. 291, 409-415.
DOI
|
58 |
Volkow, N. D., Wang, G. J., Fowler, J. S., Thanos, P. P., Logan, J.
and Gatley, S. J., (2002b) Brain DA D2 receptors predict reinforcing
effects of stimulants in humans: replication study. Synapse 46,
79-82.
DOI
|
59 |
Walker, P. D., Capodilupo J. G., Wolf W. A. and Carlock, L. R. (1996)
Preprotachykinin and preproenkephalin mRNA expression within
striatal subregions in response to altered serotonin transmission.
Brain Res. 732, 25-35.
DOI
|
60 |
White, F. J. and Kalivas, P. W. (1998) Neuroadaptations involved in
amphetamine and cocaine addiction. Drug and Alc. Dep. 51, 141-153.
DOI
|
61 |
White, F. J. and Wang, R. Y. (1984) Electrophysiological evidence for
A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine
treatment. Brain Res. 309, 283-292.
DOI
|
62 |
White, F. J., Hu, X. T., Henry, D. J. and Zhang, X. F. (1995) Neurophysiological
alterations in the mesocorticolimbic dopamine system
during repeated cocaine administration. In The Neurobiology
of Cocaine: Cellular and Molecular Mechanisms (R. P. Jr. Hammer,
Ed.), pp. 95-115. CRC Press, Boca Raton.
|
63 |
Toda, S., Shen, H. W., Peters, J., Cagle, S. and Kalivas, P. W. (2006)
Cocaine increases actin cycling: Effects in the reinstatement model
of drug seeking. J. Neurosci. 26, 1579.
DOI
|
64 |
Beitner-Johnson, D., Guitart, X. and Nestler, E. J. (1992) Neurofi lament
proteins and the mesolimbic dopamine system: common regulation
by chronic morphine and chronic cocaine in the rat ventral
tegmental area. J. Neurosci. 12, 2165-2176.
|
65 |
Banerjee, P. S., Aston, J., Khundakar, A. A. and Zetterstrom, T. S.
(2009) Differential regulation of psychostimulant-induced gene expression
of brain derived neurotrophic factor and the immediateearly
gene arc in the juvenile and adult brain Eur. J. Neurosci. 29,
465-476.
DOI
|
66 |
Barkley, R. A., Fischer, M., Smallish, L. and Fletcher, K. (2003) Does
the treatment of attention-defi cit/hyperactivity disorder with stimulants
contribute to drug use/abuse? A 13-year prospective study.
Pediatrics 111, 97-109.
DOI
|
67 |
Barron, E., Yang, P. B., Swann, A. C. and Dafny, N. (2009) Adolescent
and adult male spontaneous hyperactive rats (SHR) respond differently
to acute and chronic methylphenidate (Ritalin). Int. J. Neurosci.
119, 40-58.
DOI
|
68 |
Berke, J. D. and Hyman, S. E. (2000) Addiction, dopamine, and the
molecular mechanisms of memory. Neuron 25, 515-532.
DOI
|
69 |
Biederman, J. and Faraone, S. V. (2005) Attention-deficit hyperactivity
disorder. Lancet. 366, 237-248.
DOI
|
70 |
Todtenkopf, M. S., Parsegian, A., Naydenov, A., Neve, R. L., Konradi,
C. and Carlezon, Jr. W. A. (2006) Brain reward regulated by AMPA
receptor subunits in nucleus accumbens shell. J. Neurosci. 26,
11665-11669.
DOI
|
71 |
Unal, C. T., Beverley, J. A., Willuhn, I. and Steiner, H. (2009) Longlasting
dysregulation of gene expression in corticostriatal circuits
after repeated cocaine treatment in adult rats: effects on zif 268
and homer 1a. Eur J. Neurosci. 21, 1615-1626.
DOI
|
72 |
van der Kooij, M. A. and Glennon, J. C. (2007) Animal models concerning
the role of dopamine in attention-deficit hyperactivity disorder.
Neurosci. Biobehav. Rev. 31, 597-618.
DOI
|
73 |
Vanderschuren, L. J. and Kalivas, P. W. (2000) Alterations in dopaminergic
and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical
studies. Psychopharmacol. 151, 99-120.
DOI
|
74 |
Vendruscolo, L. F., Izidio, G. S. and Takahashi, R. N. (2009) Drug reinforcement
in a rat model of attention deficit/hyperactivity disorderthe
spontaneously hypertensive rat (SHR). Curr. Drug Abuse Rev.
2, 177-183.
DOI
|
75 |
Vezina, P. (2004) Sensitization of midbrain dopamine neuron reactivity
and the self-administration of psychomotor stimulant drugs. Neurosci.
Biobehav. Rev. 27, 827-839.
DOI
ScienceOn
|
76 |
Volkow N. D. and Swanson, J. M. (2003) Variables that affect the clinical
use and abuse of methylphenidate in the treatment of ADHD.
Am. J. Psychiatry. 160, 1909-1918.
DOI
|
77 |
Striplin, C. D. and Kalivas, P. W. (1993) Robustness of G protein
changes in cocaine sensitization shown with immunoblotting. Synapse
14, 10-15.
DOI
|
78 |
Amini, B., Yang, P. B., Swann, A. C. and Dafny, N. (2004) Differential
locomotor responses in male rats from three strains to acute methylphenidate.
Int. J. Neurosci. 114, 1063-1083.
DOI
ScienceOn
|
79 |
Ackerman, J. M. and White, F. J. (1990) A10 somatodendritic dopamine
autoreceptor sensitivity following withdrawal from repeated
cocaine treatment. Neurosci. Lett. 117, 181-187.
DOI
|
80 |
Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G.
and Perrone-Capano, C. (2006) Methylphenidate administration to
adolescent rats determines plastic changes in reward-related behavior
and striatal gene expression. Neuropsychopharmacol. 31,
1946-1956.
DOI
|
81 |
Andersen, S. L., LeBlanc, C. J. and Lyss, P. J. (2001) Maturational
increases in c-fos expression in the ascending dopamine systems.
Synapse 41, 345-350.
DOI
|
82 |
Szumlinski, K., Ary, A. W. and Lominac K. D. (2008) Homers regulate
drug-induced neuroplasticity: Implications for addiction. Biochem.
Pharmacol. 75, 112-133.
DOI
|
83 |
Swanson, J., McBurnett, K., Christian, D. and Wigal, T. (1995) Stimulant
medications and the treatment of children with ADHD. In Advances
in Clinical Psychology (T. Ollendick, R. Prinz, Eds.), pp.
265-322. Plenum Press, New York, NY.
|
84 |
Swanson, J. M., Sergeant, J. A., Taylor, E., Sonuga-Barke, E. J. S.,
Jensen, P. S. and Cantwell, D. P. (1998) Attention defi cit disorder
and hyperkinetic disorder. Lancet. 351, 429-433.
DOI
|
85 |
Swanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson,
K. A. and Bymaster, F. P. (2006) Effect of the attention deficit/hyperactivity
disorder drug atomoxetine on extracellular concentrations
of norepinephrine and dopamine in several brain regions of the rat.
Neuropharmacol. 50, 755-760.
DOI
|
86 |
Teicher, M. H., Andersen, S. L. and Hostetter, J. C. (1995) Evidence for
dopamine receptor pruning between adolescence and adulthood in
striatum but not nucleus accumbens. Dev. Brain. Res. 89, 167-172.
DOI
|
87 |
Teicher, M. H., Andersen, S. L. and Hostetter, J. C. (1995) Evidence for
dopamine receptor pruning between adolescence and adulthood in
striatum but not nucleus accumbens. Dev. Brain. Res. 89, 167-172.
DOI
|
88 |
Teicher, M. H., Anderson, C. M., Polcari, A., Glod, C. A., Maas, L. C.
and Renshaw, P. F. (2000). Functional deficits in basal ganglia of
children with attention-deficit hyperactivity disorder shown with
functional magnetic resonance imaging relaxometry. Nat. Med. 6,
470-473.
DOI
|
89 |
Thomas, U. (2002) Modulation of synaptic signalling complexes by
Homer proteins. J. Neurochem. 81, 407-413.
DOI
|
90 |
Segal, D. S. and Kuczenski, R. (1999) Escalating dose-binge treatment
with methylphenidate: role of serotonin in the emergent behavioral
prolife profile. J. Pharmacol. Exp. Ther. 291, 19-30.
|
91 |
Segal, D. S. and Kuczenski, R. (1987) Individual differences in responsiveness to single and repeated amphetamine administration:
behavioral characteristics and neurochemical correlates. J. Pharmacol.
Exp. Ther. 242, 917-926.
|
92 |
Self, D. W. and Nestler, E. J. (1995) Molecular mechanisms of drug
reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
DOI
|
93 |
Sontag, T., Tucha, O., Walitza, S. and Lange, K. W. (2010) Animal
models of attention defi cit/hyperactivity disorder (ADHD): a critical
review. ADHD Atten. Def. Hyp. Disord. 2, 1-20.
DOI
|
94 |
Sorg, B. A., Davidson, D. L., Kalivas, P. W. and Prasad, B. M. (1997)
Repeated daily cocaine alters subsequent cocaine-induced increase
of extracellular dopamine in the medial prefrontal cortex. J.
Pharmacol. Exp. Ther. 281, 54-61.
|
95 |
Spangler, R., Zhou, Y., Maggos, C. E., Schlussman, S. D., Ho, A. and
Kreek, M. J. (1997) Prodynorphin, proenkephalin and kappa opioid
receptor mRNA responses to acute ‘‘binge’’ cocaine. Brain Res.
Mol. Brain Res. 44, 139-142.
DOI
|
96 |
Starr, H. L. and Kemner, J. (2005) Multicenter, randomized, open-label
study of OROS methylphenidate versus atomoxetine: treatment
outcomes in African American children with ADHD. J. Natl. Med.
Assoc. 97, 11S-16S.
|
97 |
Steiner, H. and Gerfen, C. R. (1993) Cocaine-induced c-fos messenger
RNA is inversely related to dynorphin expression in striatum. J.
Neurosci. 13, 5066-5081.
|
98 |
Steiner, H. and Gerfen, C. R. (1998) Role of dynorphin and enkephalin
in the regulation of striatal output pathways and behavior. Exp.
Brain Res. 123, 60-76.
DOI
|
99 |
Robinson, T. E. and Kolb, B. (2004) Structural plasticity associated
with exposure to drugs of abuse. Neuropharmacol. 47, 33-46.
DOI
|
100 |
Steketee, J. D. (2005) Cortical mechanisms of cocaine sensitization.
Crit. Rev. Neurobiol. 17, 69-86.
DOI
ScienceOn
|
101 |
Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug
craving: an incentive-sensitization theory of addiction. Brain Res.
Rev. 18, 247-291.
DOI
|
102 |
Robinson, T. E. and Kolb, B. (1999) Alterations in the morphology of
dendrites and dendritic spines in the nucleus accumbens and prefrontal
cortex following repeated treatment with amphetamine or
cocaine. Eur. J. Neurosci. 11, 1598-1604.
DOI
|
103 |
Russell, V. A., Sagvolden, T. and Johansen, E. B. (2005) Animal models
of attention-defi cit hyperactivity disorder. Behav. Brain Funct.
1, 9.
DOI
|
104 |
Sagvolden, T. and Sergeant, J. A. (1998) Attention defi cit/hyperactivity
disorder--from brain dysfunctions to behaviour. Behav. Brain Res.
94, 1-10.
DOI
|
105 |
Sagvolden, T., Russell, V. A., Aase, H., Johansen, E. B. and Farshbaf,
M. (2005a) Rodent models of attention-deficit/hyperactivity disorder.
Biol. Psychiatry 57, 1239-1247.
DOI
|
106 |
Sagvolden, T., Johansen, E. B., Aase, H. and Russell, V. A. (2005b)
A dynamic developmental theory of Attention- Deficit/Hyperactivity
Disorder (ADHD) predominantly hyperactive/impulsive and combined
subtypes. Behav. Brain. Sci. 28, 397-419.
|
107 |
Sagvolden, T., Johansen, E. B., Wøien, G., Walaas, S. I., Storm-Mathisen,
J., Bergersen, L. H., Hvalby, O., Jensen, V., Aase, H., Russell,
V. A., Killeen, P. R., Dasbanerjee, T., Middleton, F. A. and Faraone
S. V. (2009) The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain. Neuropharmacol.
57, 619-626.
DOI
ScienceOn
|
108 |
Pierce, R. C., Bell, K., Duffy, P. and Kalivas, P. W. (1996) Repeated cocaine
augments excitatory amino acid transmission in the nucleus
accumbens only in rats having developed behavioral sensitization.
J. Neurosci. 16, 1550-1560.
|
109 |
See, R. E. and Kalivas, P. W. (2008) Neuroscience of substance abuse
and dependence. In Kaplan & Sadock's Comprehensive Textbook
of Psychiatry (B. J. Sadock, V. A. Sadock, P. Ruiz, Eds.), pp. 387-393. Williams & Wilkins, Lippincott.
|
110 |
Pierce, R. C. and Kalivas, P. W. (1997) A circuitry model of the expression
of behavioral sensitization to amphetamine-like psychostimulants.
Brain Res. Rev. 25, 192-216.
DOI
ScienceOn
|
111 |
Prasad, S. and Steer, S. (2008) Switching from neurostimulant therapy
to atomoxetine in children and adolescents with attention-deficit
hyperactivity disorder: clinical approaches and review of current
available evidence. Ped. Drugs 10, 39-47.
DOI
|
112 |
Pulvirenti, L., Maldonado-Lopez, R. and Koob, G. F. (1992) NMDA receptors
in the nucleus accumbens modulate intravenous cocaine
but not heroin self-administration in the rat. Brain Res. 594, 327-330.
DOI
|
113 |
Pulvirenti, L., Berrier, R., Kreifeldt, M. and Koob, G. F. (1994) Modulation
of locomotor activity by NMDA receptors in the nucleus accumbens
core and shell regions of the rat. Brain Res. 664, 231-236.
DOI
|
114 |
Rat Genome Database: 2008 (http://rgd.mcw.edu).
|
115 |
Reid, M. S. and Berger, S. P. (1996) Evidence for sensitization of
cocaine-induced mucleus accumbens glutamate release. Neuroreport
7, 1325-1329.
DOI
|
116 |
Robinson, L. M., Sclar, D. A., Skaer, T. L. and Galin, R. S. (1999) National
trends in the prevalence of attention-defi cit/hyperactivity disorder
and the prescribing of methylphenidate among school-age
children: 1990-1995. Clin. Pediatr. (Phila). 38, 209-217.
DOI
|
117 |
Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D.,
Moore, R. J. and Michelson, D. (2008) Atomoxetine and osmotically
released methylphenidate for the treatment of attention deficit
hyperactivity disorder: acute comparison and differential response.
Am. J. Psych. 165, 721-730.
DOI
|
118 |
Robinson, T. E. and Kolb, B. (1997) Persistent structural modifi cations
in nucleus accumbens and prefrontal cortex neurons produced by
previous experience with amphetamine. J. Neurosci. 21, 8491-8497.
|
119 |
Nestler E. J. (2001) Molecular basis of long-term plasticity underlying
addiction. Nat. Rev Neurosci. 2, 119-128.
DOI
|
120 |
Nestler, E. J., Terwilliger, R. Z., Walker, J. R., Sevarino, K. A. and Duman,
R. S. (1990) Chronic cocaine treatment decreases levels of
the G protein subunits and Goα in discrete regions of rat brain.
J. Neurochem. 55, 1079-1082.
DOI
|
121 |
Norrholm, S. D., Bibb, J. A., Nestler, E. J. Ouimet, C. C., Taylor. J.
R. and Greengard, P. (2003) Cocaine-induced proliferation of dendritic
spines in the nucleus accumbens is dependent on the activity
of cyclin-dependent kinase-5. Neurosci. 26, 12308-12313.
|
122 |
Okamoto, K. and Aoki, K. (1963) Development of a strain of spontaneously
hypertensive rats. Jpn. Circ. J. 27, 282-293.
DOI
ScienceOn
|
123 |
Pandolfo, P., Pamplona, F., Prediger, R. and Takahashi, R. (2007) Increased
sensitivity of adolescent spontaneously hypertensive rats,
an animal model of attention defi cit hyperactivity disorder, to the locomotor
stimulation induced by cannabinoid receptor agonist WIN
55,212-2. Eur. Jour. Pharmacol. 563, 141-148.
DOI
ScienceOn
|
124 |
Pandolfo, P., Vendruscolo, L., Sordi, R. and Takahashi, R. (2009)
Cannabinoid-induced conditioned place preference in the spontaneously
hypertensive rat-an animal model of attention deficit hyperactivity
disorder. Psychopharmacol. 205, 319-326.
DOI
|
125 |
Lin, J. S., Hou, Y. and Jouvet, M. (1996) Potential brain neuronal targets
for amphetamine-, methylphenidate-, and modafi nil-induced
wakefulness, evidenced by c-fos immunocytochemistry in the cat.
Proc. Natl. Acad. Sci. USA. 93, 14128-14133.
DOI
|
126 |
Piazza, P. V., Deminie`re, J. M., Le Moal, M. and Simon, H. (1989)
Factors that predict individual vulnerability to amphetamine self-administration,
Science 245, 1511-1513.
DOI
|
127 |
Li, Y., Kolb, B. and Robinson, T. E. (2003) The location of persistent
amphetamine-induced changes in the density of dendritic spines
on medium spiny neurons in the nucleus accumbens and caudate-putamen.
Neuropsychopharmacol. 28, 1082-5.
|
128 |
Lile, J. A., Stoops, W. W., Durell, T. M., Glaser, P. E. and Rush, C.
R. (2006) Discriminative-stimulus, self-reported, performance and
cardiovascular effects of atomoxetine in methylphenidate-trained
humans. Exp. Clin. Psychopharmacol. 14, 136-147.
DOI
|
129 |
Lu, B. and Figurov, A. (1997) Role of neurotrophins in synapse development
and plasticity. Rev. Neurosci. 8, 1-12.
DOI
|
130 |
Maganti, R. (2004) Neuroscience of psychoactive substance abuse
and dependence. Annals of Pharmacother. 38, 1-264.
|
131 |
Mandyam, C. D., Wee, S., Crawford, E. F., Eisch, A. J., Richardson, H.
N. and Koob, G. F. (2008) Varied access to intravenous methamphetamine
self-administration differentially alters adult hippocampal
neurogenesis. Biol. Psych. 64, 958-965.
DOI
|
132 |
Meredith, G. E., Callen, S. and Scheuer D. A. (2002) Brain-derived
neurotrophic factor expression is increased in the rat amygdale,
piriform cortex and hypothalamus following repeated amphetamine
administration. Brain Res. 949, 218-227.
DOI
|
133 |
Koob, G. F. and LeMoal, M. (2001) Drug addiction, dysregulation of
reward, and allostasis. Neuropsychopharmacol. 24, 97-129.
DOI
ScienceOn
|
134 |
Mijnster, M. J., Galis-de Graaf Y. and Voorn, P. (1998) Serotonergic
regulation of neuropeptide and glutamic acid decarboxylase mRNA
levels in the rat striatum and globus pallidus: studies with fl uoxetine
and DOI. Brain Res. Mol. Brain Res. 54, 64-73.
DOI
|
135 |
Nestler, E. J. (1996) Under siege: the brain on opiates. Neuron. 16,
897-900.
DOI
|
136 |
Koob, G. F., Sanna, P. P. and Bloom, F. E. (1998) Neuroscience of addiction.
Neuron 21, 467-476.
DOI
|
137 |
Kopnisky, K. L. and Hyman, S. E. (2002) Molecular and cellular biology
of addiction. In Neuropsychopharmacology: The Fifth Generation
of Progress (K. L. Davis, D. Charney, J. T. Coyle, C. Nemeroff,
Eds.), pp. 1368-1379. Lippincott Williams and Wilkins, Philadelphia.
|
138 |
Kostrzewa, R. M., Reader, T. A. and Descarries, L. (1998) Serotonin
neural adaptations to ontogenetic loss of dopamine neurons in rat
brain. J. Neurochem. 70, 889-898.
|
139 |
Korsching, S., Turgeon, S. M., Pollack, A. E. and Fink, J. S. (1993)
The neurotrophic factor concept: a reexamination. J. Neurosci. 13,
2739-2748.
|
140 |
Kuczenski, R. and Segal, D. S. (1997) Effects of methylphenidate on
extracellular dopamine, serotonin, and norepinephrine: comparison
with amphetamine. J. Neurochem. 68, 2032-2037.
|
141 |
Kuczenski, R. and Segal, D. S. (2002) Exposure of adolescent rats to
oral methylphenidate: preferential effects on extracellular norepinephrine
and absence of sensitization and cross-sensitization to
methamphetamine. J. Neurosci. 22, 7264-7271.
|
142 |
Katusic, S. K., Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Leibson,
C. L. and Jacobsen, S. J. (2005) Psychostimulant treatment
and risk for substance abuse among young adults with a history
of attentiondefi cit/hyperactivity disorder: a population-based, birth
cohort study. J. Child. Adolesc. Psychopharmacol. 15, 764-776.
DOI
ScienceOn
|
143 |
Kuczenski, R. and Segal, D. S. (2005) Stimulant actions in rodents: implications
for attention-defi cit/hyperactivity disorder treatment and
potential substance abuse. Biol. Psychiatry. 57, 1391-1396.
DOI
|
144 |
Lagace, D. C., Yee, J. K., Bolanos, C. A. and Eisch, A. J. (2006) Juvenile
administration of methylphenidate attenuates adult hippocampal
neurogenesis. Biol. Psychiatry 60, 1121-1130.
DOI
|
145 |
Lambert, N. M. and Hartsong, C. S. (1998) Prospective study of tobacco
smoking and substance dependencies among samples of
ADHD and non-ADHD participants. J. Learn. Diabil. 31, 533-544.
DOI
|
146 |
Kemner, J. E., Starr, H. L., Ciccone, P. E., Hooper-Wood, C. G. and
Crockett, R. S. (2005) Outcomes of OROSmethylphenidate compared
with atomoxetine in childrenwith ADHD: a multi-center, randomized
prospective study. Adv. Ther. 22, 498-512.
DOI
|
147 |
Kim, H. J., Park, S. H., Kyeong M. K., Ryu, J. H., Cheong, J. H. and
Shin, C. Y. (2008) Ever increasing number of animal model systems
for attention defi cit/hyperactivity disorder: attention please.
Biomol. and Ther. 16, 312-319.
DOI
|
148 |
Kim, Y., Teylan, M. A., baron, M., Sands, A., Nairn, A. C. and Greengard,
P. (2008) Methylphenidate-induced dendritic spine formation
and fosB expression in nucleus accumbens. PNAS. 106, 2915-2920.
|
149 |
Kiyatkin, E. A. and Rebec, G. V. (1996) Dopaminergic modulation of
glutamate-induced excitations of neurons in the neostriatum and
nucleus accumbens of awake, unrestrained rats. J. Neurophysiol.
75, 142-153.
|
150 |
Koda, K., Ago, Y., Cong, Y., Kita, Y., Takuma, K. and Matsuda, T.
(2010) Effects of acute and chronic administration of atomoxetine
and methylphenidate on extracellular levels of noradrenaline, dopamine
and serotonin in the prefrontal cortex and striatum of mice.
J. Neurochem. 114, 259-270.
|
151 |
Kollins, S. H., MacDonald, E. K. and Rush, C. R. (2001) Assessing
the abuse potential of methylphenidate in nonhuman and human
subjects: review. Pharmacol. Biochem. Behav. 68, 611-627.
DOI
ScienceOn
|
152 |
Kollins, S. H. (2003) Comparing the abuse potential of methylphenidate
versus other stimulants: a review of available evidence and
relevance to the ADHD patient. J. Clin. Psych. 64, 14-18.
DOI
|
153 |
Hope, B., Kosofsky, B., Hyman, S. E. and Nestler, E. J. (1992) Regulation
of immediate early gene expression and AP-1 binding in the
rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci.
USA. 89, 5764-5768.
DOI
|
154 |
Horner, K. A., Adams, D. H., Hanson, G. R. and Keefe, K. A. (2005)
Blockade of stimulant-induced preprodynorphin mRNA expression
in the striatal matrix by serotonin depletion. Neurosci. 131, 67-77.
DOI
|
155 |
Hyman, S. E. (1996) Addiction to cocaine and amphetamine. Neuron
16, 901-904.
DOI
|
156 |
Hyman, S. E. and Malenka, R. C. (2001) Addiction and the brain: the
neurobiology of compulsion and its persistence. Nat. Rev. Neurosci.
2, 695-703.
DOI
|
157 |
Jasinski, D. R., Faries, D. E., Moore, R. J., Schuh, L. M. and Allen, A. J.
(2008) Abuse liability assessment of atomoxetine in a drug-abusing
population. Drug Alcohol Depend. 95, 140-146.
DOI
|
158 |
Kalivas, P. W. (1993) Neurotransmitter regulation of dopamine neurons
in ventral tegmental area. Brain Res. Rev. 18, 75-113.
DOI
ScienceOn
|